XML 28 R8.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating activities:      
Net income $ 208.4 $ 93.7 $ 159.2
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation, depletion, and amortization 223.0 195.0 159.5
Impairment charge 1.6 5.8 0.0
Stock-based compensation expense 26.4 24.3 23.9
Gain on disposition of assets and sale of businesses (3.4) (8.2) (34.6)
Provision for deferred income taxes 26.0 25.2 31.8
(Increase) decrease in other assets 2.9 23.6 (6.4)
Increase (decrease) in other liabilities (2.6) (42.8) (7.1)
Other 13.3 0.4 6.5
Changes in current assets and liabilities:      
(Increase) decrease in receivables (69.5) 70.0 (47.8)
(Increase) decrease in inventories (72.6) 59.2 (83.5)
(Increase) decrease in other current assets 6.4 (4.3) (1.8)
Increase (decrease) in accounts payable 21.9 (48.3) 77.2
Increase (decrease) in advance billings (43.2) 66.8 (1.4)
Increase (decrease) in accrued liabilities 2.5 41.6 (14.5)
Net cash provided by operating activities 341.1 502.0 261.0
Investing activities:      
Proceeds from disposition of assets 26.6 18.3 36.6
Proceeds from sale of businesses 0.0 86.6 2.0
Capital expenditures (165.6) (189.7) (203.5)
Cash received (paid) for acquisitions 17.6 (1,424.1) (120.9)
Net cash required by investing activities (121.4) (1,508.9) (285.8)
Financing activities:      
Payments to retire debt (168.7) (502.0) (143.8)
Proceeds from issuance of debt 0.0 1,635.0 160.0
Shares repurchased 0.0 0.0 (13.8)
Dividends paid to common shareholders (10.0) (9.7) (9.8)
Purchase of shares to satisfy employee tax on vested stock (12.9) (10.6) (11.4)
Holdback payment from acquisition 0.0 0.0 (10.0)
Debt issuance costs (0.8) (23.3) (2.0)
Net cash (required) provided by financing activities (192.4) 1,089.4 (30.8)
Net increase (decrease) in cash and cash equivalents 27.3 82.5 (55.6)
Cash and cash equivalents at beginning of period 187.3 104.8 160.4
Cash and cash equivalents at end of period $ 214.6 $ 187.3 $ 104.8